Read + Share
Amedeo Smart
Independent Medical Education
Guven DC, Sahin TK, Aksoy S. The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters. Breast J 2020 Dec 4. doi: 10.1111/tbj.14126.PMID: 33274786
Email
LinkedIn
Facebook
Twitter
Privacy Policy